Jingyu Ma

474 total citations
28 papers, 265 citations indexed

About

Jingyu Ma is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jingyu Ma has authored 28 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jingyu Ma's work include Pancreatic and Hepatic Oncology Research (11 papers), Global Cancer Incidence and Screening (5 papers) and Colorectal Cancer Screening and Detection (4 papers). Jingyu Ma is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Global Cancer Incidence and Screening (5 papers) and Colorectal Cancer Screening and Detection (4 papers). Jingyu Ma collaborates with scholars based in China and United States. Jingyu Ma's co-authors include Tiebo Mao, Jiujie Cui, Weiyu Ge, Xiaofei Zhang, Yue Ming, Liwei Wang, Haiyan Xu, Haiyan Xu, Ming Quan and Shumin Li and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Hazardous Materials and International Journal of Molecular Sciences.

In The Last Decade

Jingyu Ma

27 papers receiving 262 citations

Peers

Jingyu Ma
Anna Hester Germany
Daniel Duncan United States
Daisuke Shintani Japan
Jieying Yang China
Jana Soukupová Czechia
Daniel Drescher Germany
Xinnian Yu China
Anna Hester Germany
Jingyu Ma
Citations per year, relative to Jingyu Ma Jingyu Ma (= 1×) peers Anna Hester

Countries citing papers authored by Jingyu Ma

Since Specialization
Citations

This map shows the geographic impact of Jingyu Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyu Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyu Ma more than expected).

Fields of papers citing papers by Jingyu Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyu Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyu Ma. The network helps show where Jingyu Ma may publish in the future.

Co-authorship network of co-authors of Jingyu Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyu Ma. A scholar is included among the top collaborators of Jingyu Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyu Ma. Jingyu Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Rui, Hualei Zhang, Zihan Liu, et al.. (2025). Uncovering the transcriptional regulatory network underlying selenium tolerance in maize seedlings. Journal of Hazardous Materials. 494. 138437–138437.
2.
Xu, Haiyan, Yang Sun, Jingyu Ma, et al.. (2025). CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment. Journal for ImmunoTherapy of Cancer. 13(1). e010029–e010029. 1 indexed citations
3.
4.
Zhou, Yan, et al.. (2024). Long-term trends of lung cancer incidence and survival in southeastern China, 2011–2020: a population-based study. BMC Pulmonary Medicine. 24(1). 25–25. 5 indexed citations
5.
Ge, Weiyu, Y Wang, Ming Quan, et al.. (2024). Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib. Molecular Cancer. 23(1). 48–48. 23 indexed citations
6.
Zhou, Yan, et al.. (2024). Cancer Survival Trends in Southeastern China, 2011–2021: A Population-Based Study. Clinical Epidemiology. Volume 16. 45–56. 7 indexed citations
7.
Ma, Jingyu, et al.. (2024). Temporal trends of incidence, mortality, and survival of liver cancer during 2011–2020 in Fujian Province, Southeast China. Archives of Public Health. 82(1). 233–233. 1 indexed citations
8.
Xu, Haiyan, Xiaofei Zhang, Jingyu Ma, et al.. (2024). The Role of Bile Acids in Pancreatic Cancer. Current Cancer Drug Targets. 24(10). 1005–1014. 2 indexed citations
9.
Ge, Weiyu, Yue Ming, Tianhao Zhou, et al.. (2023). PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells. Cancer Letters. 558. 216095–216095. 44 indexed citations
10.
Li, Shumin, Yue Ming, Haiyan Xu, et al.. (2023). Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer. Cancer Letters. 564. 216206–216206. 43 indexed citations
11.
Ge, Weiyu, Jiujie Cui, Xiaofei Zhang, et al.. (2023). Cuproptosis‐related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients. IET Systems Biology. 17(4). 174–186. 6 indexed citations
12.
Ge, Weiyu, Tiebo Mao, Xiaofei Zhang, et al.. (2022). Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer. Disease Markers. 2022. 1–22. 10 indexed citations
13.
Ge, Weiyu, Kexuan Wang, Tiebo Mao, et al.. (2022). Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma. Frontiers in Cell and Developmental Biology. 10. 942225–942225. 6 indexed citations
14.
Ge, Weiyu, Yongchao Wang, Yanling Wang, et al.. (2022). A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer. Frontiers in Cell and Developmental Biology. 10. 1001606–1001606. 3 indexed citations
15.
Zhang, Zheying, Yifei Han, Jingyu Ma, et al.. (2022). Hsa_Circ_0000826 inhibits the proliferation of colorectal cancer by targeting AUF1. Journal of genetics and genomics. 50(3). 192–203. 10 indexed citations
16.
Ge, Weiyu, Ruirong Lin, Tianhao Zhou, et al.. (2022). PLA2G2A Cancer-Associated Fibroblasts Mediate Pancreatic Cancer Immune Escape Via Impeding Antitumor Immune Response of CD8 Cytotoxic T Cells. SSRN Electronic Journal. 7 indexed citations
17.
Mao, Tiebo, Xiaofei Zhang, Haiyan Xu, et al.. (2022). HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53. Cancer Cell International. 22(1). 380–380. 4 indexed citations
18.
Guo, Zengqing, et al.. (2022). Time Trend of Upper Gastrointestinal Cancer Incidence in China from 1990 to 2019 and Analysis Using an Age–Period–Cohort Model. Current Oncology. 29(10). 7470–7481. 4 indexed citations
19.
20.
Ma, Jingyu, et al.. (2015). [Analysis of cancer incidence and mortality from cancer registries of Fujian province in 2011].. PubMed. 49(8). 738–40. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Hester Breakdown of academic impact, for papers by Daniel Duncan Breakdown of academic impact, for papers by Daisuke Shintani Breakdown of academic impact, for papers by Jieying Yang Breakdown of academic impact, for papers by Jana Soukupová Breakdown of academic impact, for papers by Daniel Drescher Breakdown of academic impact, for papers by Xinnian Yu
Rankless by CCL
2026